Compare
Cannaisseur Group Inc. vs Cyanotech Corp vs Natural Alternatives International Inc vs USANA Health Sciences Inc
| Latest fiscal year | Cannaisseur Group Inc. TCRG | Cyanotech Corp CYANLast annual report: year ended 2025-03-31 | Natural Alternatives International Inc NAII | USANA Health Sciences Inc USNA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-03-31 | 2026-06-30 | 2026-01-03 |
| Revenue | $0 | $24.21M | $142.51M | $925.26M |
| Revenue growth (YoY) | -100.0% | +5.0% | +9.7% | +8.3% |
| Gross margin | n/a | 28.4% | 6.3% | 78.3% |
| Operating margin | n/a | -10.4% | -13.2% | 4.0% |
| Net margin | n/a | -13.2% | -14.5% | 1.2% |
| Net income | -$1.77M | -$3.20M | -$20.70M | $10.76M |
| EPS (Diluted) | -$0.03 | n/a | -$3.43 | $0.58 |
| Operating cash flow | -$127.5K | -$1.19M | -$8.92M | $22.35M |
| Free cash flow | n/a | n/a | -$12.62M | $8.53M |
| Cash & equivalents | $22 | $257.0K | $7.39M | $158.38M |
| Total assets | $140 | $23.49M | $126.45M | $742.91M |
| Total liabilities | $235.4K | $14.61M | $76.49M | $156.64M |
| Shareholders' equity | -$235.3K | $8.88M | $49.96M | $533.10M |
| Return on year-end equity | n/a | -36.1% | -41.4% | 2.0% |
| Shares outstanding | 60.46M | 7.20M | 6.27M | 18.28M |
Revenue, most recent five fiscal years
| Fiscal year | Cannaisseur Group Inc. | Cyanotech Corp | Natural Alternatives International Inc | USANA Health Sciences Inc |
|---|---|---|---|---|
| Latest | $0 Ended 2025-12-31 | $24.21M Ended 2025-03-31 | $142.51M Ended 2026-06-30 | $925.26M Ended 2026-01-03 |
| 1 year earlier | $700 Ended 2024-12-31 | $23.07M Ended 2024-03-31 | $129.86M Ended 2025-06-30 | $854.50M Ended 2024-12-28 |
| 2 years earlier | $53.1K Ended 2023-12-31 | $23.18M Ended 2023-03-31 | $113.80M Ended 2024-06-30 | $921.01M Ended 2023-12-30 |
| 3 years earlier | $88.1K Ended 2022-12-31 | $35.97M Ended 2022-03-31 | $154.01M Ended 2023-06-30 | $998.60M Ended 2022-12-31 |
| 4 years earlier | n/a | $32.34M Ended 2021-03-31 | $170.97M Ended 2022-06-30 | $1.19B Ended 2022-01-01 |